Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Varuma
Cambridge, Massachusetts, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Varuma is a private biotechnology company focused on developing novel therapies for respiratory diseases, specifically chronic obstructive pulmonary disease (COPD) and asthma. The company is primarily engaged in the development of long-acting muscarinic antagonists (LAMA) designed to provide superior bronchodilation and improved patient outcomes. Varuma's lead program, VRM-001, is a small molecule candidate currently in the pre-clinical stage of development. The company was founded by experienced life science investors and entrepreneurs with the goal of addressing significant unmet needs in the management of chronic airway diseases.
- Therapeutic areas
- Pulmonology
- Modalities
- Small molecule
- Industry
- Biotech
Beyond the preview
Go deeper on Varuma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Varuma.